🔎 Trials Near Me

Hjem › Kolorektal kreft › Oregon

Kliniske studier for Kolorektal kreft i Oregon

29 studier for Kolorektal kreft søker deltakere på steder i Oregon.

Byer i Oregon

Offisiell studietekst (engelsk)

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

  • Oregon Health and Science University, Portland
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05673148

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

  • Oregon Health & Science University (Knight Cancer Institute), Portland
Rekrutterer
Alder 65 til 82 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05612347

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Oregon Health & Science University (OHSU), Portland
RekruttererFase 1/2
Alder 12 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT04585750

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Saint Alphonsus Cancer Care Center-Baker City, Baker City
  • Saint Charles Health System, Bend
  • Clackamas Radiation Oncology Center, Clackamas
  • og 7 flere
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069

Family Communications After Genetic Testing

  • Saint Alphonsus Cancer Care Center-Baker City, Baker City
  • Saint Charles Health System, Bend
  • Clackamas Radiation Oncology Center, Clackamas
  • og 7 flere
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07143487

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

  • Exelixis Clinical Site #51, Portland
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT05176483

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

  • ALX Center 6, Portland
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07085091

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

  • Research Site, Portland
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT05877599

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  • Oncology Associates of Oregon, P.C., Albany
  • Kaiser Permanente Sunnyside Medical Center, Clackamas
  • Oncology Associates of Oregon, P.C., Corvallis
  • og 4 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07222800

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

  • Research Site, Portland
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06218914

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

  • Oregon Health And Science University, Portland
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06750094

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

  • St Charles Medical Center, Bend
  • Oregon Health And Science University, Portland
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06662786

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

  • Oregon Health and Science University, Portland
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT05863195

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

  • Hematology Oncology Salem, Salem
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 11. sep. 2026 · NCT04929223

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

  • Research Site, Portland
RekruttererFase 2
Alder 18 til 130 · Alle kjønn · Oppdatert 18. aug. 2026 · NCT06792695

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • Oregon Health and Science University, Portland
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT05919264

A Study of MGC026 in Participants With Advanced Solid Tumors

  • Providence Cancer Institute, Portland
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT06242470

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • Oregon Health & Science University, Portland
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. jul. 2026 · NCT04657068

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

  • Investigative Site #121, Portland
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 23. jul. 2026 · NCT06974110

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

  • Northwest Cancer Specialists, P.C, Happy Valley
  • Providence Cancer Institute Newberg Clinic, Newberg
  • Providence Cancer Institute Willamette Falls Clinic, Oregon City
  • og 8 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. jul. 2026 · NCT05253651

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

  • OHSU Knight Cancer Institute, Portland
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 16. jul. 2026 · NCT05705492

A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

  • Oncology Associates of Oregon - Primary, Eugene
  • Northwest Cancer Specialists - Compass, Portland
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 12. jun. 2026 · NCT07011576

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

  • Saint Alphonsus Cancer Care Center-Baker City, Baker City
  • Saint Charles Health System, Bend
  • Clackamas Radiation Oncology Center, Clackamas
  • og 8 flere
RekruttererFase 3Frivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 31. mar. 2026 · NCT07018869

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Saint Alphonsus Cancer Care Center-Baker City, Baker City
  • Saint Alphonsus Cancer Care Center-Ontario, Ontario
  • Kaiser Permanente Northwest, Portland
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 17. mar. 2026 · NCT06418204

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Oregon Health Sciences University, Portland
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 og eldre · Alle kjønn · Oppdatert 20. jan. 2026 · NCT05366881

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

  • Providence Newberg Medical Center, Newberg
  • Providence Willamette Falls Medical Center, Oregon City
  • Providence Portland Medical Center, Portland
  • og 1 flere
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 9. jan. 2026 · NCT06073431

Evaluation of Gixam's Performance in a FIT Negative Population

  • The Oregon Clinic Gastroenterology-East, Portland
RekruttererFase 2
Alder 45 til 85 · Alle kjønn · Oppdatert 14. nov. 2024 · NCT06612281

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.